GI Section, George E Wahlen Department of Veterans Affairs Medical Center;
Ther Clin Risk Manag. 2009 Feb;5(1):65-73. Epub 2009 Mar 26.
The use of non-steroidal anti-inflammatory drugs has become ubiquitous worldwide and remains a common source of gastrointestinal morbidity. Antisecretory medications, particularly proton pump inhibitors, are effective in the treatment and prevention of NSAID-related gastrointestinal complications, including peptic ulcer disease and non-ulcer dyspepsia. A careful assessment of patients' risk factors for developing NSAID-related gastrointestinal complications should be undertaken prior to initiation of any NSAIDs. Patients who are considered at risk for developing gastrointestinal complications should receive concurrent antisecretory medical therapy to minimize the risk for GI complications.
非甾体抗炎药的使用已在全球范围内无处不在,仍然是胃肠道发病的常见原因。抗分泌药物,特别是质子泵抑制剂,在治疗和预防 NSAID 相关胃肠道并发症方面非常有效,包括消化性溃疡病和非溃疡性消化不良。在开始使用任何 NSAIDs 之前,应仔细评估患者发生 NSAID 相关胃肠道并发症的危险因素。被认为有发生胃肠道并发症风险的患者应接受同时进行的抗分泌药物治疗,以最大程度地降低 GI 并发症的风险。